• Wed news: BioNTech buying Biotheus. FDA’s Califf lists hopes for his successor. Amgen loses $12B market cap from hidden spreadsheet tab. TRex Bio raises $84M. London is Europe’s life science capitol. See more on our front page

Chiesi starts rare diseases division, ahead of potential Fabry disease filing

cafead

Administrator
Staff member
  • cafead   Feb 18, 2020 at 10:32: AM
via Italian pharma Chiesi has begun a new rare diseases division as it builds towards a potential commercial launch for its Fabry Disease therapy.

article source